doi:10.1038/s43016-025-01282-0 Jovanovski E, Mazhar N, Komishon A, et al
Other research suggests that GLP-1s may help reduce thromboembolic events, such as deep vein thrombosis (DVT), in people with obesity and autoimmune diseases
Many patients and providers consider these medications together when managing type 2 diabetes or prediabetes, but understanding how they differ is essential for tailored treatment
And part of the reason for that is our societys cultural baggage
This integrated model ensures members get the best possible outcome, with or without GLP-1s
Documented protocols maintain a fasted state for optimal GH response, and community sources describe running each peptide separately first to assess individual response before combining